SymBio Pharmaceuticals' Series E Round

SymBio Pharmaceuticals raised a round of funding on February 28, 2011.

SymBio Pharmaceuticals operates as a biopharmaceutical company for treating low-grade non-Hodgkin's lymphoma and chronic lymphatic leukemia in Singapore.…

Articles about SymBio Pharmaceuticals' Series E Round: